Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins

Abstract

This study provided a proof of principle in showing that a panel of circulating protein biomarkers may improve lung cancer risk assessment and may be used to define eligibility for computed tomography screening.